Clinical Trials Browser

Phase 1/2 × Recruiting × Smoldering Multiple Myeloma × Clear all

NCT05841550 2025-08-05

The TG01 Study With TG01/QS-21 Vaccine in Patients With High-risk Smouldering Multiple Myeloma and Multiple Myeloma

Phase 1/2 Recruiting

Smoldering Multiple Myeloma, Multiple Myeloma